- This event has passed.
AMGEN Lecture Series: Biotechnology Edge
May 13, 2021 - May 14, 2021
This two-day lecture series is presented by AMGEN scientists, in partnership with the School of Pharmacy and Bouvé College of Health Sciences Dean’s office. It will provide participants with an overview of the drug development process, as well as the biotechnology industry and potential career paths. Lectures will be presented live online. Recording is not allowed. See the full program below.
The lectures will be in real time on WebEx. A link will be sent to everyone who has registered. Attendees of the two-day lecture series will be eligible to earn a Badge.
| Thursday May 13th 2021, 9.00 am – 4.30 pm | |
| 9.00 | Introduction |
| 9.10 | Life of a Drug, Roger Hart, PhD |
| 10.00 | Drug Discovery at Amgen: A Multi‐Modality Approach, Roger Hart, PhD |
| 10.50 | Break and Informational Session |
| 11.10 | Process Development from Clinic to Approval, Jennifer Litowski,Process Development Principal Scientist |
| 12.00 | Lunch and Learn |
| 1.00 | Target Identification & Validation, John Ferbas, PhD, |
| 1.50 | Introduction to Pharmaceutical Solid-State Chemistry and MaterialsScience, Hyunsoo Park, Process Development Principal Scientist |
| 2.40 | Break |
| 2.50 | From Bench to Bedside: Discovery of the First FDA‐ ApprovedAntibody Therapeutic for Migraine, Cen Xu, PhD |
| 3.40 | The Role of Continuous Manufacturing to Advance Amgen’s SyntheticPortfolio, Matt Beaver, Principal Scientist |
| Friday, May 14th 2021, 9.00 am – 4.30 pm | |
| 9.00 | Introduction |
| 9.10 | Drug Safety: An Industry Perspective Oluwadamilola Ogunyankin,MD,MPH |
| 10.00 | Modeling of Processes, Products and Devices for Drug Development &Manufacturing, Pablo Rolandi, Director Data Sciences |
| 10.50 | Break and Informational Session |
| 11.10 | Raw Material Selection and Control for ManufacturingPharmaceuticals, Susan Burke, PhD |
| 12.00 | Lunch and Learn |
| 1.00 | Oncology, Kristin Tarbell, Principal Scientist |
| 1.50 | Innovations in Device Technologies for Delivering Biologics to Patients,Shirish Ingawale, PhD |
| 2.40 | Break |
| 2.50 | Digital Transformation in Biopharmaceutical Operations, Myra Coufal,PhD |
| 3.40 | Careers in Biotech, Jessica Smith, Process Development AssociateScientist |